NT5C2変異性急性リンパ性白血病におけるクローン進化メカニズム
Gannie Tzoneva1, Chelsea L Dieck1, Koichi Oshima1
1Institute for Cancer Genetics, Columbia University, New York, New York 10032, USA.
Nature
|January 18, 2018
まとめ
NT5C2遺伝子の機能獲得変異は,化学療法に対する耐性を引き起こすことで,急性リンパ性白血病 (ALL) を再発させた. IMPDHを阻害することで,NT5C2変異性ALLを治療する見込みがある.
科学分野:
- * 血液学
- * 分子生物学
- * がん研究
背景:
- * 急性リンパ性白血病 (ALL) の再発は予後が悪く,化学療法に対する耐性がある.
- * 5'- ヌクレオチダゼ,細胞性II (NT5C2) 遺伝子の機能獲得変異は,再発性ALLにおける6 - メルカプトプリン耐性に関連しています.
- * 白血病の発症,進行,再発におけるNT5C2変異によるクローン進化のメカニズムは完全に理解されていません.
研究 の 目的:
- * 再発性ALLのクローン進化におけるNT5C2変異の役割を調査する.
- * NT5C2変異が化学療法に耐性を与えるメカニズムを解明する.
- * NT5C2変異性ALLを標的とした潜在的な治療戦略を探求する.
主な方法:
- * マウスの条件付きおよび誘導性白血病モデルを使用した.
- * 流通しているNT5C2 ((R367Q)) 変異を白血病細胞に導入した.
- * 評価された化学療法耐性,細胞増殖,および白血病を誘発する細胞活動
- * ピューリンの代謝と細胞外ピューリンの輸出を分析した.
- * イノシン5'- モノフォスファート脱水素酶 (IMPDH) 抑制の有効性を評価した.
主要な成果:
- * NT5C2 ((R367Q) の発現により,6-メルカプトプリン化学療法に対する耐性が生じた.
- * NT5C2変異は白血病細胞の増殖を阻害し,白血病を誘発する細胞の活性を低下させた.
- * 変異細胞は過剰な細胞外ピューリン排出と細胞内ピューリン核酸プール減少を示した.
- * IMPDHの抑制により,NT5C2変異性白血病リンパ細胞に対する細胞毒性が著しく増加した.
結論:
- * NT5C2変異は,白血病細胞にフィットネスコストを課し,クローン進化に影響を与えます.
- * 化学療法に対する耐性と健康維持コストは,ALLの再発の主要な要因です.
- * IMPDHの抑制はNT5C2変異性ALLの治療における潜在的な治療方法である.
さらに関連する動画
06:48In Ovo Xenografting of Patient-Derived Acute Lymphoblastic Leukemia (ALL) Cells (PDX-ALL)
Published on: August 1, 2025
574
15:07VDJ-Seq: Deep Sequencing Analysis of Rearranged Immunoglobulin Heavy Chain Gene to Reveal Clonal Evolution Patterns of B Cell Lymphoma
Published on: December 28, 2015
27.3K
関連する概念動画
The Evidence for Evolution
48.5K
Genetic variations accumulating within populations over generations give rise to biological evolution. Evolutionary changes can result in the formation of novel varieties and entire new species. These changes are responsible for the diverse forms of life inhabiting the planet. The evidence for evolution suggests that all living organisms descended from common ancestors.
48.5K
Convergent Evolution
33.1K
Evolution shapes the features of organisms over time, ensuring that they are suited for the environments in which they live. Sometimes, selection pressure leads to the rise of similar but unrelated adaptations in organisms with no recent common ancestors, a process known as convergent evolution.
33.1K
Eukaryotic Evolution
42.5K
The endosymbiont theory is the most widely accepted theory of eukaryotic evolution; however, its progression is still somewhat debated. According to the nucleus-first hypothesis, the ancestral prokaryote first evolved a membrane to enclose DNA and form the nucleus. Conversely, the mitochondria-first hypothesis suggests that the nucleus was formed after endosymbiosis of mitochondria.
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...
Contrary to the endosymbiont theory, the eukaryote-first hypothesis proposes that the simpler prokaryotic and...
42.5K
Synteny and Evolution
3.8K
John H. Renwick first coined the term “synteny” in 1971, which refers to the genes present on the same chromosomes, even if they are not genetically linked. The species with common ancestry tend to show conserved syntenic regions. Therefore, the concept of synteny is nowadays used to describe the evolutionary relationship between species.
Around 80 million years ago, the human and mice lineages diverged from the common ancestor. During the course of evolution, the ancestral...
Around 80 million years ago, the human and mice lineages diverged from the common ancestor. During the course of evolution, the ancestral...
3.8K
T Cell Activation and Clonal Selection
16.4K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
16.4K
Gene Evolution - Fast or Slow?
3.7K
3.7K
